BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10734174)

  • 21. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.
    Bhardwaj RK; Glaeser H; Becquemont L; Klotz U; Gupta SK; Fromm MF
    J Pharmacol Exp Ther; 2002 Aug; 302(2):645-50. PubMed ID: 12130727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).
    Dintaman JM; Silverman JA
    Pharm Res; 1999 Oct; 16(10):1550-6. PubMed ID: 10554096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.
    Di Marco MP; Edwards DJ; Wainer IW; Ducharme MP
    Life Sci; 2002 Jul; 71(10):1149-60. PubMed ID: 12095536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.
    Katoh M; Nakajima M; Yamazaki H; Yokoi T
    Pharm Res; 2000 Oct; 17(10):1189-97. PubMed ID: 11145223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier.
    Matsuzaki J; Yamamoto C; Miyama T; Takanaga H; Matsuo H; Ishizuka H; Kawahara Y; Kuwano M; Naito M; Tsuruo T; Sawada Y
    Biopharm Drug Dispos; 1999 Mar; 20(2):85-90. PubMed ID: 10206323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of P-glycoprotein transport function by grapefruit juice psoralen.
    Wang EJ; Casciano CN; Clement RP; Johnson WW
    Pharm Res; 2001 Apr; 18(4):432-8. PubMed ID: 11451028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.
    Fujimoto H; Higuchi M; Watanabe H; Koh Y; Ghosh AK; Mitsuya H; Tanoue N; Hamada A; Saito H
    Biol Pharm Bull; 2009 Sep; 32(9):1588-93. PubMed ID: 19721237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function.
    Patanasethanont D; Nagai J; Yumoto R; Murakami T; Sutthanut K; Sripanidkulchai BO; Yenjai C; Takano M
    J Pharm Sci; 2007 Jan; 96(1):223-33. PubMed ID: 17031860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
    Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
    Lown KS; Bailey DG; Fontana RJ; Janardan SK; Adair CH; Fortlage LA; Brown MB; Guo W; Watkins PB
    J Clin Invest; 1997 May; 99(10):2545-53. PubMed ID: 9153299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism-based inhibition of recombinant human cytochrome P450 3A4 by tomato juice extract.
    Sunaga K; Ohkawa K; Nakamura K; Ohkubo A; Harada S; Tsuda T
    Biol Pharm Bull; 2012; 35(3):329-34. PubMed ID: 22382318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of P-glycoprotein inhibitors on cadmium accumulation in cultured renal epithelial cells, LLC-PK1, and OK.
    Endo T; Kimura O; Sakata M
    Toxicol Appl Pharmacol; 2002 Dec; 185(3):166-71. PubMed ID: 12498733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice.
    Edwards DJ; Bernier SM
    Life Sci; 1996; 59(13):1025-30. PubMed ID: 8809221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine.
    Chan WK; Nguyen LT; Miller VP; Harris RZ
    Life Sci; 1998; 62(10):PL135-42. PubMed ID: 9496718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
    Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K
    Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
    Yamazaki H; Shimada T
    Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein.
    Iwanaga K; Hayashi M; Hamahata Y; Miyazaki M; Shibano M; Taniguchi M; Baba K; Kakemi M
    Drug Metab Dispos; 2010 Aug; 38(8):1286-94. PubMed ID: 20463004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD
    Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
    Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.